Intrinsic Edge Capital Management LLC Rhythm Pharmaceuticals, Inc. Transaction History
Intrinsic Edge Capital Management LLC
- $678 Million
- Q4 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 50,000 shares of RYTM stock, worth $2.61 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$2.61 Million% of portfolio
0.17%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RYTM
# of Institutions
216Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$353 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$344 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$318 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$318 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$192 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.91B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...